Osbon Capital Management LLC
Source: SEC Form 13F · as of Mar 2026Osbon Capital Management LLC holds 22 biotech & pharma companies tracked by BioSniper, totaling $2.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$2.0M
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 3,344 | $1.2M |
| MRKMerck & Co., Inc. | 2,171 | $261K |
| JNJJOHNSON & JOHNSON | 706 | $173K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 504 | $136K |
| ABBVAbbVie Inc. | 326 | $71K |
| BMYBRISTOL MYERS SQUIBB CO | 1,014 | $61K |
| PFEPFIZER INC | 981 | $28K |
| PMPhilip Morris International Inc | 148 | $24K |
| INSMINSMED Inc | 137 | $22K |
| LLYELI LILLY & Co | 24 | $22K |
| ABTABBOTT LABORATORIES | 175 | $18K |
| GILDGILEAD SCIENCES, INC. | 90 | $13K |
| TWSTTwist Bioscience Corp | 200 | $10K |
| GEHCGE HealthCare Technologies Inc. | 100 | $7K |
| MCKMcKesson Corporation | 8 | $7K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 18 | $6K |
| CLPTClearPoint Neuro Inc. | 402 | $4K |
| SLDBSolid Biosciences Inc. | 501 | $4K |
| RAREUltragenyx Pharmaceutical Inc. | 86 | $2K |
| VTRSViatris Inc | 121 | $2K |
| OGNOrganon & Co. | 200 | $1K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1 | $447 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.